Isolation and characterization of two bacteriophages with strong in vitro antimicrobial activity against Pseudomonas aeruginosa isolated from dogs with ocular infections

American Journal of Veterinary Research

Volumn 72, Issue 8, 2011, Pages 1079-1086

  Santos, Thiago M A ^a   Ledbetter, Eric C ^a   Caixeta, Luciano S ^a   Bicalho, Marcela L S ^a   Bicalho, Rodrigo C ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DNA; P2S2; P5U5; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIOPHAGE; BACTERIUM ISOLATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DOG; DOSE RESPONSE; EYE INFECTION; HOST; IN VITRO STUDY; KERATITIS; NONHUMAN; PH; PROTEIN ANALYSIS; PSEUDOMONAS AERUGINOSA; THERMOSTABILITY;

ANIMALS; BACTERIOPHAGE TYPING; BACTERIOPHAGES; CORNEAL ULCER; DNA, VIRAL; DOG DISEASES; DOGS; EYE INFECTIONS; GENETIC VARIATION; HOST SPECIFICITY; PODOVIRIDAE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SIPHOVIRIDAE;

BACTERIA (MICROORGANISMS); CANIS FAMILIARIS; PODOVIRIDAE; PSEUDOMONAS AERUGINOSA; SIPHOVIRIDAE;

EID: 80052759800     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.72.8.1079     Document Type: Article

References (31)

1. Lyczak JB, Cannon CL, Pier GB. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect 2000;2:1051-1060.
2. Ledbetter EC, Mun JJ, Kowbel D, et al. Pathogenic phenotype and genotype of Pseudomonas aeruginosa isolates from spontaneous canine ocular infections. Invest Ophthalmol Vis Sci 2009;50:729-736.
3. Fleiszig SM, Evans DJ. The pathogenesis of bacterial kera-titis: studies with Pseudomonas aeruginosa. Clin Exp Optom 2002;85:271-278.
4. Green M, Apel A, Stapleton F. Risk factors and causative organisms in microbial keratitis. Cornea 2008;27:22-27.
5. Hall-Stoodley L, Costerton J W, Stoodley P. Bacterial bioflms: from the natural environment to infectious diseases. Nat Rev Microbiol 2004;2:95-108.
6. Li XZ, Livermore DM, Nikaido H. Role of effux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tet-racycline, chloramphenicol, and norfoxacin. Antimicrob Agents Chemother 1994;38:1732-1741.
7. Nikaido H. Prevention of drug access to bacterial targets: permeability barriers and active effux. Science 1994;264:382-388.
8. Burgos JM, Ellington BA, Varela M F. Presence of multidrug-resistant enteric bacteria in dairy farm topsoil. J Dairy Sci 2005;88:1391-1398.
9. Daly M, Power E, Bjorkroth J, et al. Molecular analysis of Pseudomonas aeruginosa: epidemiological investigation of mastitis outbreaks in Irish dairy herds. Appl Environ Microbiol 1999;65:2723-2729.
10. Sela S, Hammer-Muntz O, Krifucks O, et al. Phenotypic and genotypic characterization of Pseudomonas aeruginosa strains isolated from mastitis outbreaks in dairy herds. J Dairy Res 2007;74:425-429.
11. Viscardi M, Perugini AG, Auriemma C, et al. Isolation and characterisation of two novel coliphages with high potential to control antibiotic-resistant pathogenic Escherichia coli (EHEC and EPEC). Int J Antimicrob Agents 2008;31:152-157.
12. Soothill JS. Treatment of experimental infections of mice with bacteriophages. J Med Microbiol 1992;37:258-261.
13. Callaway TR, Edrington TS, Brabban AD, et al. Bacteriophage isolated from feedlot cattle can reduce Escherichia coli O157:H7 populations in ruminant gastrointestinal tracts. Foodborne Pat-hog Dis 2008;5:183-191.
14. Matsuzaki S, Yasuda M, Nishikawa H, et al. Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage phi MR11. J Infect Dis 2003;187:613-624.
15. Biswas B, Adhya S, Washart P, et al. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-re-sistant Enterococcus faecium. Infect Immun 2002;70:204-210.
16. Donlan RM. Preventing bioflms of clinically relevant organisms using bacteriophage. Trends Microbiol 2009;17:66-72.
17. Sambrook J, Russell D W. Molecular cloning: a laboratory manual. 3rd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 2001.
18. Kropinski AM, Mazzocco A, Waddell TE, et al. Enumeration of bacteriophages by double agar overlay plaque assay. Methods Mol Biol 2009;501:69-76.
19. International Committee on Taxonomy of Viruses website. Available at: www.ictvdb.org. Accessed May 2, 2011.
20. Brussow H, Hendrix RW. Phage genomics: small is beautiful. Cell 2002;108:13-16.
21. Fischetti VA, Nelson D, Schuch R. Reinventing phage therapy: are the parts greater than the sum? Nat Biotechnol 2006;24:1508-1511.
22. Bicalho RC, Santos TM, Gilbert RO, et al. Susceptibility of Escherichia coli isolated from uteri of postpartum dairy cows to antibiotic and environmental bacteriophages. Part I: isolation and lytic activity estimation of bacteriophages. J Dairy Sci 2010;93:93-104.
23. Santos TM, Gilbert RO, Caixeta LS, et al. Susceptibility of Escherichia coli isolated from uteri of postpartum dairy cows to antibiotic and environmental bacteriophages. Part II: in vitro antimicrobial activity evaluation of a bacteriophage cocktail and several antibiotics. J Dairy Sci 2010;93:105-114.
24. Ma YL, Lu C P. Isolation and identifcation of a bacteriophage ca-pable of infecting Streptococcus suis type 2 strains. Vet Microbiol 2008;132:340-347.
25. Gurnev PA, Oppenheim AB, Winterhalter M, et al. Docking of a single phage lambda to its membrane receptor maltoporin as a time-resolved event. J Mol Biol 2006;359:1447-1455.
26. Fineran PC, Blower TR, Foulds IJ, et al. The phage abortive infection system, ToxIN, functions as a protein-RNA toxin-antitoxin pair. Proc Natl Acad Sci U S A 2009;106:894-899.
27. Barrangou R, Fremaux C, Deveau H, et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science 2007;315:1709-1712.
28. Heo YJ, Chung IY, Choi KB, et al. Genome sequence comparison and superinfection between two related Pseudo-monas aeruginosa phages, D3112 and MP22. Microbiology 2007;153:2885-2895.
29. Jepson CD, March JB. Bacteriophage lambda is a highly stable DNA vaccine delivery vehicle. Vaccine 2004;22:2413-2419.
30. O'Flynn G, Coffey A, Fitzgerald G F, et al. The newly isolated lyt-ic bacteriophages st104a and st104b are highly virulent against Salmonella enterica. J Appl Microbiol 2006;101:251-259.
31. Synnott AJ, Kuang Y, Kurimoto M, et al. Isolation from sewage influent and characterization of novel Staphylococcus aureus bacteriophages with wide host ranges and potent lytic capabilities. Appl Environ Microbiol 2009;75:4483-4490.